Works about RITONAVIR
Results: 1062
Short- and long-term comparative effectiveness of nirmatrelvir/ritonavir and molnupiravir in asthma patients: a cohort study.
- Published in:
- Respiratory Research, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s12931-025-03156-2
- By:
- Publication type:
- Article
Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A Phase 3 Randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2025, v. 80, n. 2, p. 323, doi. 10.1093/cid/ciae551
- By:
- Publication type:
- Article
Nirmatrelvir plus ritonavir in COVID-19: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 2, p. 41, doi. 10.1007/s40267-022-00971-1
- By:
- Publication type:
- Article
Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efavirenz Conceptions and Regimen Management in a Prospective Cohort of Women on Antiretroviral Therapy.
- Published in:
- Infectious Diseases in Obstetrics & Gynecology, 2012, p. 1, doi. 10.1155/2012/723096
- By:
- Publication type:
- Article
Planning and Evaluation of Bioequivalence Studies of Lopinavir/Ritonavir Preparations.
- Published in:
- Pharmaceutical Chemistry Journal, 2020, v. 53, n. 12, p. 1101, doi. 10.1007/s11094-020-02130-0
- By:
- Publication type:
- Article
INFLUENCE OF HYDRATION AND THE SIZE OF THE MACROCYCLE OF NATIVE CYCLODEXTRINS ON THE SOLID PHASE INCLUSION OF RITONAVIR.
- Published in:
- Journal of Structural Chemistry, 2023, v. 64, n. 9, p. 1702, doi. 10.1134/S0022476623090135
- By:
- Publication type:
- Article
The Safety and Efficacy of Lonafarnib Boosted with Ritonavir with or without Peginterferon Alfa in Patients with Chronic Hepatitis Delta.
- Published in:
- touchREVIEWS in Infectious Diseases, 2023, v. 2, n. 1, p. 5, doi. 10.17925/id.2023.3.1.5
- By:
- Publication type:
- Article
Long-term Follow-up Liver Stiffness Results of Chronic Hepatitis C Patients Treated with Direct-acting Antivirals.
- Published in:
- Journal of Tepecik Education & Research Hospital / İzmir Tepecik Eğitim ve Araştırma Hastanesi Dergisi, 2023, v. 33, n. 1, p. 76, doi. 10.4274/terh.galenos.2022.68736
- By:
- Publication type:
- Article
Comparative Performance Evaluation of Personal Protective Measures and Antiviral Agents Against SARS-CoV-2 Variants: A Narrative Review.
- Published in:
- Clinical Pathology, 2023, p. 1, doi. 10.1177/2632010X231161222
- By:
- Publication type:
- Article
Comparative Performance Evaluation of Personal Protective Measures and Antiviral Agents Against SARS-CoV-2 Variants: A Narrative Review.
- Published in:
- Clinical Pathology, 2023, v. 16, p. 1, doi. 10.1177/2632010X231161222
- By:
- Publication type:
- Article
The efficacy and safety of ombitasvir/paritaprevir/ritonavir plus ribavirin in hepatitis C virus‑infected patients with end‑stage renal disease on regular hemodialysis.
- Published in:
- Journal of Medicine in Scientific Research, 2021, v. 4, n. 2, p. 170, doi. 10.4103/jmisr.jmisr_114_20
- By:
- Publication type:
- Article
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir Regimen in Haemodialysis Patients With Hepatitis C Virus Infection: A Case Series.
- Published in:
- Croatian Journal of Infection / Infektoloski Glasnik, 2019, v. 39, n. 1, p. 23, doi. 10.37797/ig.39.1.4
- By:
- Publication type:
- Article
Novel 1,3-Indanedione-Thiazole Hybrids as Small-Molecule SARS-COV-2 Main Protease Inhibitors With Potential anti-Coronaviral Activity.
- Published in:
- Polycyclic Aromatic Compounds, 2024, v. 44, n. 10, p. 6941, doi. 10.1080/10406638.2024.2318442
- By:
- Publication type:
- Article
Investigating Graph Invariants for Predicting Properties of Chemical Structures of Antiviral Drugs.
- Published in:
- Polycyclic Aromatic Compounds, 2024, v. 44, n. 10, p. 6696, doi. 10.1080/10406638.2023.2283625
- By:
- Publication type:
- Article
Melatonin and alpha lipoic acid attenuate lopinavir/ritonavir - induced testicular toxicity in albino rats.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2016, v. 62, n. 2, p. 17, doi. 10.33320/maced.pharm.bull.2016.62.02.002
- By:
- Publication type:
- Article
Recent Analytical Methodologies for Determination of Anti-Viral COVID-19 Drugs: A Review.
- Published in:
- Egyptian Academic Journal of Biological Sciences, C Physiology & Molecular Biology, 2024, v. 16, n. 1, p. 431, doi. 10.21608/EAJBSC.2024.361129
- By:
- Publication type:
- Article
High Detection Rate of HIV Drug Resistance Mutations among Patients Who Fail Combined Antiretroviral Therapy in Manaus, Brazil.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5567332
- By:
- Publication type:
- Article
Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre.
- Published in:
- Global Cardiology Science & Practice, 2021, v. 2021, n. 2, p. 1, doi. 10.21542/gcsp.2021.11
- By:
- Publication type:
- Article
QSPR/QSAR study of antiviral drugs modeled as multigraphs by using TI's and MLR method to treat COVID-19 disease.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-63007-w
- By:
- Publication type:
- Article
Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 9, p. 1273, doi. 10.3390/biom13091273
- By:
- Publication type:
- Article
Acquired HIV-1 Protease Conformational Flexibility Associated with Lopinavir Failure May Shape the Outcome of Darunavir Therapy after Antiretroviral Therapy Switch.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 4, p. 489, doi. 10.3390/biom11040489
- By:
- Publication type:
- Article
Molnupiravir as the COVID-19 panacea: false beliefs in low- and middle-income countries.
- Published in:
- Pathogens & Global Health, 2023, v. 117, n. 6, p. 525, doi. 10.1080/20477724.2023.2232593
- By:
- Publication type:
- Article
miRNA-218 Targets Lipin-1 and Glucose Transporter Type 4 Genes in 3T3-L1 Cells Treated With Lopinavir/Ritonavir.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00461
- By:
- Publication type:
- Article
Nonprogressive CMV retinitis in AIDS patients with protease inhibitors therapy for AIDS.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM).
- Published in:
- PharmacoEconomics, 2019, v. 37, n. 12, p. 505, doi. 10.1007/s41669-019-0130-7
- By:
- Publication type:
- Article
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Lopinavir/Ritonavir Versus Darunavir Plus Ritonavir for HIV Infection: A Cost-Effectiveness Analysis for the United States.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 5, p. 427, doi. 10.1007/s40273-013-0048-3
- By:
- Publication type:
- Article
High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Effect of Paxlovid in COVID-19 treatment during the periods of SARS-CoV-2 Omicron BA.5 and BN.1 subvariant dominance in the Republic of Korea: a retrospective cohort study.
- Published in:
- Osong Public Health & Research Perspectives, 2024, v. 15, n. 2, p. 137, doi. 10.24171/j.phrp.2023.0230
- By:
- Publication type:
- Article
The effectiveness of Paxlovid treatment in long-term care facilities in South Korea during the outbreak of the Omicron variant of SARS-CoV-2.
- Published in:
- Osong Public Health & Research Perspectives, 2022, v. 13, n. 6, p. 443, doi. 10.24171/j.phrp.2022.0262
- By:
- Publication type:
- Article
DETERMINATION OF SOLUBILITY OF CEFPODOXIME PROXETIL (CLASS IV) AND RITONAVIR (CLASS II) IN DIFFERENT OILS.
- Published in:
- Pharma Science Monitor, 2017, v. 8, n. 4, p. 302
- By:
- Publication type:
- Article
Antiviral Therapy of COVID-19.
- Published in:
- Scripta Medica, 2020, v. 51, n. 3, p. 131, doi. 10.5937/scriptamed51-28336
- By:
- Publication type:
- Article
Efficacy and Safety of Novel Oral Antivirals in Hospitalized COVID-19 Patients: A Network Meta-Analysis of Randomized Clinical Trials.
- Published in:
- Clinical Epidemiology, 2023, v. 15, p. 1041, doi. 10.2147/CLEP.S422386
- By:
- Publication type:
- Article
Effectiveness of 8- and 12-Week Treatment with Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve HCV Patients in a Real-Life Setting in Romania: the AMETHYST Study.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2021, v. 30, n. 1, p. 88, doi. 10.15403/jgld-3373
- By:
- Publication type:
- Article
Safety Profile of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Hepatitis C in Romania: an Analysis Conducted in VigiBase®/WHO.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2020, v. 29, n. 4, p. 603, doi. 10.15403/jgld-2889
- By:
- Publication type:
- Article
Real-Life Use of 3 Direct-Acting Antiviral Regimen in a Large Cohort of Patients with Genotype-1b HCV Compensated Cirrhosis.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2017, v. 26, n. 3, p. 275, doi. 10.15403/jgld.2014.1121.263.iac
- By:
- Publication type:
- Article
Potential pitfalls of Viekira Pak™ therapy in patients with HCV genotype 1b cirrhosis.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Fatal acute liver failure during Ritonavirboosted Paritaprevir, Ombitasvir and Dasabuvir plus Ribavirin therapy.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
A Case of Acute Liver Failure during Ritonavir-Boosted Paritaprevir, Ombitasvir and Dasabuvir Therapy in a Patient with HCV Genotype 1b Cirrhosis.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2016, v. 25, n. 4, p. 559, doi. 10.15403/jgld.2014.1121.254.tti
- By:
- Publication type:
- Article
Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 12, p. 1223, doi. 10.1001/jama.2015.1328
- By:
- Publication type:
- Article
Nirmatrelvir Plus Ritonavir for Ambulatory COVID-19: Expanding Evidence, Expanding Role.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 1, p. 133, doi. 10.7326/M22-3427
- By:
- Publication type:
- Article
Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System: A Population-Based Cohort Study.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 1, p. 77, doi. 10.7326/M22-2141
- By:
- Publication type:
- Article
Polymorphisms and drug resistance analysis of HIV-1 isolates from patients on first line antiretroviral therapy (ART) in South-eastern Nigeria.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0231031
- By:
- Publication type:
- Article
HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells.
- Published in:
- PLoS ONE, 2020, v. 15, n. 1, p. 1, doi. 10.1371/journal.pone.0226924
- By:
- Publication type:
- Article
A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study).
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0222650
- By:
- Publication type:
- Article
Dolutegravir based antiretroviral therapy compared to other combined antiretroviral regimens for the treatment of HIV-infected naive patients: A systematic review and meta-analysis.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0222229
- By:
- Publication type:
- Article
Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0221653
- By:
- Publication type:
- Article
Understanding acceptance of and adherence to a new formulation of paediatric antiretroviral treatment in the form of pellets (LPV/r)—A realist evaluation.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0220408
- By:
- Publication type:
- Article